FBXO11 governs macrophage cell death and inflammation in response to bacterial toxins
Life Science Alliance · 2023-06 · 6 (6) · e202201735
DOI: 10.26508/lsa.202201735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 28.03.2023. Verfasst von Yusun Jeon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia. Hauptthemen laut MEDLINE: Bacterial Toxins, F-Box Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DHAC | National Health and Medical Research Council, Department of Education and Training | Australian Research Council.
Abstract (Originalsprache)
Staphylococcus aureus causes severe infections such as pneumonia and sepsis depending on the pore-forming toxin Panton–Valentine leukocidin (PVL). PVL kills and induces inflammation in macrophages and other myeloid cells by interacting with the human cell surface receptor, complement 5a receptor 1 (C5aR1). C5aR1 expression is tighly regulated and may thus modulate PVL activity, although the mechanisms involved remain incompletely understood. Here, we used a genome-wide CRISPR/Cas9 screen and identified F-box protein 11 (FBXO11), an E3 ubiquitin ligase complex member, to promote PVL toxicity. Genetic deletion of FBXO11 reduced the expression of C5aR1 at the mRNA level, whereas ectopic expression of C5aR1 in FBXO11 −/− macrophages, or priming with LPS, restored C5aR1 expression and thereby PVL toxicity. In addition to promoting PVL-mediated killing, FBXO11 dampens secretion of IL-1β after NLRP3 activation in response to bacterial toxins by reducing mRNA levels in a BCL-6–dependent and BCL-6–independent manner. Overall, these findings highlight that FBXO11 regulates C5aR1 and IL-1β expression and controls macrophage cell death and inflammation following PVL exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia.
- The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
- The Department of Medical Biology, University of Melbourne, Parkville, Australia.
- The Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
- Department of Medicine, University of Cambridge, Cambridge, UK.
- Department of Biochemistry & Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia Thomas.naderer@monash.edu.
ORCID-Profile: Thomas Naderer
Förderung
- DHAC | National Health and Medical Research Council
- Department of Education and Training | Australian Research Council
Zitieren
APA
Jeon, Y., Chow, S. H., Stuart, I., Weir, A., Yeung, A. T., Hale, C., Sridhar, S., Dougan, G., Vince, J. E., & Naderer, T. (2023). FBXO11 governs macrophage cell death and inflammation in response to bacterial toxins. Life Science Alliance, 6(6), e202201735. https://doi.org/10.26508/lsa.202201735
Vancouver
Jeon Y, Chow SH, Stuart I, Weir A, Yeung AT, Hale C, et al. FBXO11 governs macrophage cell death and inflammation in response to bacterial toxins. Life Science Alliance. 2023;6(6):e202201735. doi:10.26508/lsa.202201735
BibTeX
@article{Jeon2023,
author = {Jeon, Yusun and Chow, Seong H and Stuart, Isabella and Weir, Ashley and Yeung, Amy Ty and Hale, Christine and Sridhar, Sushmita and Dougan, Gordon and Vince, James E and Naderer, Thomas},
title = {FBXO11 governs macrophage cell death and inflammation in response to bacterial toxins},
journal = {Life Science Alliance},
year = {2023},
volume = {6},
number = {6},
pages = {e202201735},
doi = {10.26508/lsa.202201735}
}
EUVIMED